Skeletal Traction in Children: A New Device

Mittal, Ravi; Singh, Tulica; Rastogi, Sanjay

doi:10.1177/004947559802800413

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…India has 29 states and 7 union territories [ 7 ], with a seroprevalence of 60%-80% of hepatitis A infection noted among children aged ≤ 5 years in various states in India [ 8 , 9 ].…”

Section: Introductionmentioning

confidence: 99%

“…Among 29 Indian states, Kerala state reported the lowest HAV antibody seroprevalence rate (4.3%-10.3%) among children and individuals aged ≤ 15 years [ 8 – 10 ]. With the decreasing number of adolescents with prior exposure to HAV, several hepatitis A outbreaks occurred, specifically, with high attack rate among this population in Kerala [ 11 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Cost-effective analysis of hepatitis A vaccination in Kerala state, India

Gurav,

Bagepally,

Chitpim

et al. 2024

PLoS ONE

View full text Add to dashboard Cite

Several hepatitis A outbreaks have recently been reported in Kerala state, India. To inform coverage decision of hepatitis A vaccine in Kerala, this study aimed to examine the cost-effectiveness of 1) hepatitis A vaccination among children aged 1 year and individuals aged 15 years, and 2) serological screening of individuals aged 15 years and vaccination of susceptible as compared to no vaccination or vaccination without serological screening. Both live attenuated hepatitis A vaccine and inactivated hepatitis A vaccine were considered in the analysis. A combination of decision tree and Markov models with a cycle length of one year was employed to estimate costs and benefits of different vaccination strategies. Analysis were based on both societal and payer perspectives. The lifetime costs and outcomes were discounted by 3%. Our findings indicated that all strategies were cost-saving for both societal and payer perspectives. Moreover, budget impact analysis revealed that vaccination without screening among individuals aged 15 years could save the government’s budget by reducing treatment cost of hepatitis A. Our cost-effectiveness evidence supports the inclusion of hepatitis A vaccination into the vaccination program for children aged 1 year and individuals aged 15 years in Kerala state, India.

show abstract

“…India has 29 states and 7 union territories [ 7 ], with a seroprevalence of 60%-80% of hepatitis A infection noted among children aged ≤ 5 years in various states in India [ 8 , 9 ].…”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%